Malaysia Stock Market Due For Support On Friday

RTTNews | 339 dias atrás
Malaysia Stock Market Due For Support On Friday

(RTTNews) - The Malaysia stock market has moved lower in three straight sessions, slumping more than 20 points or 1.4 percent along the way. The Kuala Lumpur Composite Index now rests just beneath the 1,385-point plateau although it's expected to see bargain hunting on Friday.

The global forecast for the Asian markets is upbeat on progress to end the debt ceiling situation in the United States. The European and U.S. markets mere up and the Asian bourses figure to follow that lead.

The KLCI finished slightly lower on Thursday following losses from the telecoms, support from the plantations and a mixed picture from the financial sector.

For the day, the index slipped 4.11 points or 0.30 percent to finish at 1,383.01 after trading between 1,378.58 and 1,386.41.

Among the actives, Axiata added 0.72 percent, while Celcomdigi tumbled 2.01 percent, CIMB Group advanced 0.83 percent, Dialog Group plummeted 3.24 percent, Genting slumped 1.19 percent, IHH Healthcare shed 0.52 percent, Inari declined 1.59 percent, IOI Corporation rose 0.54 percent, Kuala Lumpur Kepong gained 0.67 percent, Maxis rallied 2.19 percent, Maybank dropped 0.58 percent, MISC tanked 2.05 percent, MRDIY stumbled 1.27 percent, Petronas Chemicals skidded 1.07 percent, PPB Group plunged 2.21 percent, Press Metal jumped 1.95 percent, Public Bank collected 0.52 percent, RHB Capital lost 0.37 percent, Sime Darby retreated 1.45 percent, Tenaga Nasional sank 0.53 percent and Sime Darby Plantations, Telekom Malaysia, Genting Malaysia and AMMB Holdings were unchanged.

The lead from Wall Street is solid as the major averages quickly shook off a sluggish start and moved firmly into the green.

The Dow climbed 153.30 points or 0.47 percent to finish at 33,061.57, while the NASDAQ surged 165.70 points or 1.28 percent to end at 13,100.98 and the S&P 500 advanced 41.19 points or 0.99 percent to close at 4,221.02.

The strength that emerged on Wall Street came after the House voted Wednesday night to approve the bill raising the U.S. debt ceiling.

The legislation now heads to the Senate, where Majority Leader Chuck Schumer, D-N.Y., said he hopes lawmakers can work quickly and bring the bill to the president's desk "as soon as possible."

In economic news, payroll processor ADP said private sector employment in the U.S. jumped more than expected in May. Also, the Labor Department noted a slight increase in first-time claims for U.S. unemployment benefits last week.

Crude oil prices rose sharply Thursday on hopes OPEC will announce a cut in production. Oil prices were also supported by a weak U.S. dollar and the passage of the debt ceiling bill. West Texas Intermediate crude futures for July ended higher by $2.01 or 3 percent at $70.10 per barrel.

read more
Cohen & Co. Swings To Net Profit In Q1; Revenues Soar

Cohen & Co. Swings To Net Profit In Q1; Revenues Soar

Financial services company Cohen & Co. Inc. (COHN) reported Monday net income attributable to Company for the first quarter of $2.02 million or $1.28 per share, compared to a net loss of $2.64 million or $1.77 per share in the prior-year quarter.
RTTNews | 4h 10min atrás
Eurozone Private Sector Growth Accelerates In April

Eurozone Private Sector Growth Accelerates In April

The euro area private sector growth accelerated to an 11-month high in April driven by the service sector, final survey results from S&P Global showed on Monday. The HCOB composite output index rose to 51.7 in April from 50.3 in the previous month. The flash estimate was 51.4.
RTTNews | 4h 20min atrás
TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator

TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator

Biotechnology company TC BioPharm (Holdings) plc (TCBP) announced Monday the execution of a non-binding letter of intent to acquire a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory cancers and solid tumors.
RTTNews | 4h 41min atrás
Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation

Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation

Bristol Myers Squibb Co. (BMY) announced Monday that the European Medicines Agency (EMA) has validated its Type II variation application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adult patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC).
RTTNews | 5h 21min atrás
Bay Street Likely To Open On Firm Note

Bay Street Likely To Open On Firm Note

Higher Canadian and U.S. futures, and rising crude oil and bullion prices point to a positive start on Bay Street Monday morning. Optimism about rate cuts by the Fed and several central banks in Europe is also expected to aid market's rise.
RTTNews | 5h 25min atrás
BioNTech Slips To Loss In Q1

BioNTech Slips To Loss In Q1

Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a net loss of 315.1 million euros or 1.31 euros per share for the first quarter, compared to net profit of 502.2 million euros or 2.05 euros per share in the prior-year quarter.
RTTNews | 6h 27min atrás